Elevance Health, Inc. (ELV) To Go Ex-Dividend on June 10th

Elevance Health, Inc. (NYSE:ELV) declared a quarterly dividend on Tuesday, April 21st. Investors of record on Wednesday, June 10th will be paid a dividend of 1.72 per share on Thursday, June 25th. This represents a c) annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, June 10th.

Elevance Health has raised its dividend by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 14 years. Elevance Health has a payout ratio of 17.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Elevance Health to earn $29.08 per share next year, which means the company should continue to be able to cover its $6.88 annual dividend with an expected future payout ratio of 23.7%.

Elevance Health Trading Down 0.5%

NYSE:ELV opened at $326.32 on Thursday. Elevance Health has a 12 month low of $273.71 and a 12 month high of $432.93. The firm has a market cap of $71.68 billion, a price-to-earnings ratio of 12.99, a P/E/G ratio of 1.81 and a beta of 0.49. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.70. The company’s 50 day moving average is $308.80 and its 200-day moving average is $331.56.

Elevance Health (NYSE:ELV) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, beating analysts’ consensus estimates of $10.74 by $1.84. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The company had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. During the same quarter last year, the firm posted $11.97 earnings per share. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities analysts anticipate that Elevance Health will post 25.75 EPS for the current year.

Hedge Funds Weigh In On Elevance Health

A number of institutional investors and hedge funds have recently bought and sold shares of ELV. Physician Wealth Advisors Inc. increased its position in Elevance Health by 331.6% during the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock worth $26,000 after acquiring an additional 63 shares during the period. Activest Wealth Management boosted its stake in Elevance Health by 66.7% during the third quarter. Activest Wealth Management now owns 85 shares of the company’s stock worth $27,000 after buying an additional 34 shares in the last quarter. Rossby Financial LCC boosted its stake in Elevance Health by 110.0% during the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock worth $28,000 after buying an additional 44 shares in the last quarter. Kemnay Advisory Services Inc. acquired a new stake in Elevance Health during the fourth quarter worth $31,000. Finally, Motco boosted its stake in Elevance Health by 334.8% during the third quarter. Motco now owns 100 shares of the company’s stock worth $32,000 after buying an additional 77 shares in the last quarter. Institutional investors own 89.24% of the company’s stock.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.